Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07106372) titled 'A Study of Stapokibatrt in Children Subjects With Atopic Dermatitis' on Aug. 5.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Keymed Biosciences Co.Ltd
Condition:
Atopic Dermatitis
Intervention:
Biological: Stapokibatrt
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: September 2025
Target Sample Size: 240
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07106372
Published by HT Digital Content Services w...